Přejít k obsahu
Merck

No carcinogenicity of ethyl tertiary-butyl ether by 2-year oral administration in rats.

The Journal of toxicological sciences (2012-12-05)
Masaaki Suzuki, Kazunori Yamazaki, Hirokazu Kano, Shigetoshi Aiso, Kasuke Nagano, Shoji Fukushima
ANOTACE

The carcinogenicity of ethyl tertiary-butyl ether (ETBE) was examined by oral administration using F344/DuCrlCrlj rats. Groups of 50 male and 50 female rats were given drinking water containing ETBE at doses of 0, 625, 2,500 or 10,000 ppm (w/w) for 104 weeks. No significant increase in the incidence of tumors was detected in any organ of either sex. Rat-specific non-neoplastic lesions were observed in the kidney: An increase in the severity of chronic progressive nephropathy was observed in the male and female 10,000 ppm groups, and increased incidences of urothelial hyperplasia of the pelvis and mineral deposition in the renal papilla were observed in the male 2,500 and 10,000 ppm groups. Besides these lesions, no treatment-related histopathological changes were observed in any organ or tissue in either sex. Thus, the present study demonstrated that a two year administration ETBE in the drinking water did not exert any carcinogenic effects in either male or female rats.

MATERIÁLY
Číslo produktu
Značka
Popis produktu

Supelco
tert-Butyl ethyl ether, analytical standard
Sigma-Aldrich
tert-Butyl ethyl ether, 99%
Sigma-Aldrich
tert-Butyl ethyl ether, purum, ≥97.0% (GC)